Dose of Remi in Children (DRINK)

Zhihong LU

Status: Not yet enrolling

Conditions: Anesthesia

Treatments: Drug: Remimazolam

Study type: Interventional

Funder types: Other

Identifiers

NCT05990673

XJH-A-20230606

Details and patient eligibility

About

Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, the effective dosage of remimazolam in pediatric patients is still unknown.

Enrollment: 25 estimated patients

Sex: All

Ages: 3 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age from 3 to 12 years old
• patients scheduled for surgery under general anesthesia

Exclusion criteria

• American Society of Anesthesiologists status >=Ⅲ
• Body mass index>=28kg/m2
• patients who cannot cooperate with intravenous anesthesia induction
• patients with risk of difficult airway
• patients who are allergic to benzodiazepines
• patients with delayed neurologic function

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Sequential Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

remimazolam

Experimental group

Description:

remimazolam is given for anesthesia induction

Treatment:

Drug: Remimazolam